These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 20069395

  • 1. Overexpression of cortactin increases invasion potential in oral squamous cell carcinoma.
    Yamada S, Yanamoto S, Kawasaki G, Mizuno A, Nemoto TK.
    Pathol Oncol Res; 2010 Dec; 16(4):523-31. PubMed ID: 20069395
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of CRKII increases migration and invasive potential in oral squamous cell carcinoma.
    Yamada S, Yanamoto S, Kawasaki G, Rokutanda S, Yonezawa H, Kawakita A, Nemoto TK.
    Cancer Lett; 2011 Apr 28; 303(2):84-91. PubMed ID: 21339045
    [Abstract] [Full Text] [Related]

  • 3. RNAi-mediated down-regulation of alpha-actinin-4 decreases invasion potential in oral squamous cell carcinoma.
    Yamada S, Yanamoto S, Yoshida H, Yoshitomi I, Kawasaki G, Mizuno A, Nemoto TK.
    Int J Oral Maxillofac Surg; 2010 Jan 28; 39(1):61-7. PubMed ID: 19913389
    [Abstract] [Full Text] [Related]

  • 4. Cortactin is a prognostic marker for oral squamous cell carcinoma and its overexpression is involved in oral carcinogenesis.
    Liu YC, Ho HC, Lee MR, Yeh CM, Tseng HC, Lin YC, Chung JG.
    Environ Toxicol; 2017 Mar 28; 32(3):799-812. PubMed ID: 27148699
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
    Rothschild BL, Shim AH, Ammer AG, Kelley LC, Irby KB, Head JA, Chen L, Varella-Garcia M, Sacks PG, Frederick B, Raben D, Weed SA.
    Cancer Res; 2006 Aug 15; 66(16):8017-25. PubMed ID: 16912177
    [Abstract] [Full Text] [Related]

  • 7. Aberrant expression of the tight junction molecules claudin-1 and zonula occludens-1 mediates cell growth and invasion in oral squamous cell carcinoma.
    Babkair H, Yamazaki M, Uddin MS, Maruyama S, Abé T, Essa A, Sumita Y, Ahsan MS, Swelam W, Cheng J, Saku T.
    Hum Pathol; 2016 Nov 15; 57():51-60. PubMed ID: 27436828
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy.
    Yanamoto S, Kawasaki G, Yoshitomi I, Iwamoto T, Hirata K, Mizuno A.
    Oral Oncol; 2007 Oct 15; 43(9):869-77. PubMed ID: 17207659
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An update of knowledge on cortactin as a metastatic driver and potential therapeutic target in oral squamous cell carcinoma.
    Ramos-García P, González-Moles MÁ, González-Ruiz L, Ayén Á, Ruiz-Ávila I, Navarro-Triviño FJ, Gil-Montoya JA.
    Oral Dis; 2019 May 15; 25(4):949-971. PubMed ID: 29878474
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Podocalyxin-like 1 is associated with tumor aggressiveness and metastatic gene expression in human oral squamous cell carcinoma.
    Lin CW, Sun MS, Wu HC.
    Int J Oncol; 2014 Aug 15; 45(2):710-8. PubMed ID: 24821609
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G, Santoro A, Feola A, Bufo P, Papagerakis P, Lo Muzio L, Staibano S, Ionna F, Longo F, Franco R, Aquino G, Contaldo M, De Maria S, Serpico R, De Rosa A, Rubini C, Papagerakis S, Giovane A, Tombolini V, Giordano A, Caraglia M, Di Domenico M.
    Curr Cancer Drug Targets; 2014 Aug 15; 14(2):115-27. PubMed ID: 24274398
    [Abstract] [Full Text] [Related]

  • 17. A role for aberrantly expressed nuclear localized decorin in migration and invasion of dysplastic and malignant oral epithelial cells.
    Dil N, Banerjee AG.
    Head Neck Oncol; 2011 Sep 29; 3():44. PubMed ID: 21958730
    [Abstract] [Full Text] [Related]

  • 18. Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma.
    Dos Reis PP, Bharadwaj RR, Machado J, Macmillan C, Pintilie M, Sukhai MA, Perez-Ordonez B, Gullane P, Irish J, Kamel-Reid S.
    Cancer; 2008 Dec 01; 113(11):3169-80. PubMed ID: 18991282
    [Abstract] [Full Text] [Related]

  • 19. Cortactin expression in a Norwegian cohort of human papilloma virus negative oral squamous cell carcinomas of the mobile tongue.
    Sengüven Toközlü B, Sapkota D, Vallenari EM, Schreurs O, Søland TM.
    Eur J Oral Sci; 2023 Apr 01; 131(2):e12925. PubMed ID: 36790139
    [Abstract] [Full Text] [Related]

  • 20. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L, Wang Y, Xiao M, Lin Y, Yu L.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct 01; 110(4):484-91. PubMed ID: 20868995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.